Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 45

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis

Yin, Juntao, Wei, Lunshou, Wang, Naiqin, Li, Xiumin, Miao, Mingsan·2022·Journal of Ethnopharmacology
DOI 10.1016/j.jep.2022.115041
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jep.2022.115041

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 69

  1. Alizadeh, 2018, Curcumin nanomicelle improves semen parameters, oxidative stress, inflammatory biomarkers, and reproductive hormones in infertile men: a randomized clinical trial, Phytother Res., 32, 514, 10.1002/ptr.5998 · DOI
  2. Amalraj, 2017, Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives - a review, J Tradit Complement Med, 7, 205, 10.1016/j.jtcme.2016.05.005 · DOI
  3. Amalraj, 2017, A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study, J. Med. Food, 20, 1022, 10.1089/jmf.2017.3930 · DOI
  4. Amin, 2015, Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - a double blind randomized controlled trial - TAK-MetS trial, Compl. Ther. Med., 23, 165, 10.1016/j.ctim.2015.01.008 · DOI
  5. Anand, 2007, Bioavailability of curcumin: problems and promises, Mol. Pharm., 4, 807, 10.1021/mp700113r · DOI · Paper page
  6. Asteriou, 2018, Curcumin for the management of periodontitis and early ACPA-positive rheumatoid arthritis: killing two birds with one stone, Nutrients, 10, 908, 10.3390/nu10070908 · DOI
  7. Bahramsoltani, 2017, Pharmacokinetic interactions of curcuminoids with conventional drugs: a review, J. Ethnopharmacol., 209, 1, 10.1016/j.jep.2017.07.022 · DOI
  8. Banerjee, 2021, Novel bioenhanced curcumin With mesalamine for induction of clinical and endoscopic remission in mild-to-moderate ulcerative colitis: a randomized double-blind placebo-controlled pilot study, J. Clin. Gastroenterol., 55, 702, 10.1097/MCG.0000000000001416 · DOI
  9. Baumgart, 2007, Inflammatory bowel disease: clinical aspects and established and evolving therapies, Lancet, 369, 1641, 10.1016/S0140-6736(07)60751-X · DOI · Paper page
  10. Bommelaer, 2020, Oral curcumin No more effective than placebo in preventing recurrence of crohn’s disease after surgery in a randomized controlled trial, Clin. Gastroenterol. Hepatol., 18, 1553, 10.1016/j.cgh.2019.08.041 · DOI
  11. Burge, 2019, Curcumin and intestinal inflammatory diseases: molecular mechanisms of protection, Int. J. Mol. Sci., 20, 1912, 10.3390/ijms20081912 · DOI
  12. Carbonnel, 2016, Methotrexate is not superior to placebo for inducing steroid-free remission, but induces steroid-free clinical remission in a larger proportion of patients with ulcerative colitis, Gastroenterology, 150, 380, 10.1053/j.gastro.2015.10.050 · DOI
  13. Fan, 2020, Curcumin, as a pleiotropic agent, improves doxorubicin-induced nephrotic syndrome in rats, J. Ethnopharmacol., 250, 112502, 10.1016/j.jep.2019.112502 · DOI
  14. Ghosh, 2015, The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update, Food Chem. Toxicol., 83, 111, 10.1016/j.fct.2015.05.022 · DOI
  15. Gopi, 2017, Comparative oral absorption of curcumin in a natural turmeric matrix with two other curcumin formulations: an open-label parallel-arm study, Phytother Res., 31, 1883, 10.1002/ptr.5931 · DOI
  16. Grammatikopoulou, 2018, Oral adjuvant curcumin therapy for attaining clinical remission in ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials, Nutrients, 10, 1737, 10.3390/nu10111737 · DOI · Paper page
  17. Gupta, 2013, Therapeutic roles of curcumin: lessons learned from clinical trials, AAPS J., 15, 195, 10.1208/s12248-012-9432-8 · DOI · Paper page
  18. Hanai, 2006, Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial, Clin. Gastroenterol. Hepatol., 4, 1502, 10.1016/j.cgh.2006.08.008 · DOI · Paper page
  19. Hanauer, 2004, Medical therapy for ulcerative colitis 2004, Gastroenterology, 126, 1582, 10.1053/j.gastro.2004.02.071 · DOI
  20. Hanauer, 2006, Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities, Inflamm. Bowel Dis., 12, S3, 10.1097/01.MIB.0000195385.19268.68 · DOI
  21. Hibi, 2006, Novel pathophysiological concepts of inflammatory bowel disease, J. Gastroenterol., 41, 10, 10.1007/s00535-005-1744-3 · DOI
  22. Higgins, 2003, Measuring inconsistency in meta-analyses, Bmj, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  23. Hussain, 2017, Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: a review of new trends and state-of-the-art, Colloids Surf. B Biointerfaces, 150, 223, 10.1016/j.colsurfb.2016.11.036 · DOI
  24. Ihara, 2017, TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota, J. Gastroenterol., 52, 777, 10.1007/s00535-017-1350-1 · DOI
  25. Iqbal, 2018, Use of curcumin in achieving clinical and endoscopic remission in ulcerative colitis: a systematic review and meta-analysis, Am. J. Med. Sci., 356, 350, 10.1016/j.amjms.2018.06.023 · DOI
  26. Jobin, 1999, Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity, J. Immunol., 163, 3474, 10.4049/jimmunol.163.6.3474 · DOI
  27. Kaiser, 1999, Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes, Gastroenterology, 116, 602, 10.1016/S0016-5085(99)70182-4 · DOI
  28. Kedia, 2017, Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: results from a randomized double blind placebo controlled trial, World J. Gastrointest. Pharmacol. Therapeut, 8, 147, 10.4292/wjgpt.v8.i2.147 · DOI · Paper page
  29. Ko, 2019, AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis, Gastroenterology, 156, 748, 10.1053/j.gastro.2018.12.009 · DOI · Paper page
  30. Kunnumakkara, 2017, Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases, Br. J. Pharmacol., 174, 1325, 10.1111/bph.13621 · DOI
  31. Lang, 2015, Curcumin add-on therapy for induction of remission in mild-moderate active Ulcerative Colitis: A multi-center, prospective, randomized, double-blind, placebo-controlled trial, J. Crohns Colitis, 9, S300
  32. Levine, 2017, Mesalamine enemas for induction of remission in oral mesalamine-refractory pediatric ulcerative colitis: a prospective cohort study, J Crohns Colitis, 11, 970, 10.1093/ecco-jcc/jjx042 · DOI
  33. Lang, 2015, Curcumin in combination With mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial, Clin. Gastroenterol. Hepatol., 13, 1444, 10.1016/j.cgh.2015.02.019 · DOI · Paper page
  34. Levine, 2002, A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis, Am. J. Gastroenterol., 97, 1398
  35. Li, 2020, Curcumin metabolites contribute to the effect of curcumin on ameliorating insulin sensitivity in high-glucose-induced insulin-resistant HepG2 cells, J. Ethnopharmacol., 259, 113015, 10.1016/j.jep.2020.113015 · DOI
  36. Liu, 2015, Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine: executive summary, Compl. Ther. Med., 23, 751, 10.1016/j.ctim.2015.08.001 · DOI
  37. Liu, 2013, Curcumin ameliorates dextran sulfate sodium-induced experimental colitis by blocking STAT3 signaling pathway, Int. Immunopharm., 17, 314, 10.1016/j.intimp.2013.06.020 · DOI
  38. Marteau, 2005, Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study, Gut, 54, 960, 10.1136/gut.2004.060103 · DOI
  39. Masoodi, 2018, The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients' self-reported well-being: a randomized double-blind controlled trial, J. Cell. Biochem., 119, 9552, 10.1002/jcb.27273 · DOI · Paper page
  40. Midura-Kiela, 2012, Curcumin inhibits interferon-γ signaling in colonic epithelial cells, Am. J. Physiol. Gastrointest. Liver Physiol., 302, G85, 10.1152/ajpgi.00275.2011 · DOI
  41. Mirzaei, 2017, Phytosomal curcumin: a review of pharmacokinetic, experimental and clinical studies, Biomed. Pharmacother., 85, 102, 10.1016/j.biopha.2016.11.098 · DOI · Paper page
  42. Nakase, 2021, Evidence-based clinical practice guidelines for inflammatory bowel disease 2020, J. Gastroenterol., 56, 489, 10.1007/s00535-021-01784-1 · DOI
  43. Negi, 1999, Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture, J. Agric. Food Chem., 47, 4297, 10.1021/jf990308d · DOI
  44. Neurath, 2014, Cytokines in inflammatory bowel disease, Nat. Rev. Immunol., 14, 329, 10.1038/nri3661 · DOI · Paper page
  45. Okuda, 2019, The additive effects of low dose intake of ferulic acid, phosphatidylserine and curcumin, not alone, improve cognitive function in APPswe/PS1dE9 transgenic mice, Biol. Pharm. Bull., 42, 1694, 10.1248/bpb.b19-00332 · DOI
  46. Panahi, 2017, Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial, Compl. Ther. Med., 33, 1, 10.1016/j.ctim.2017.05.006 · DOI
  47. Prasad, 2014, Curcumin, a component of golden spice: from bedside to bench and back, Biotechnol. Adv., 32, 1053, 10.1016/j.biotechadv.2014.04.004 · DOI
  48. Priyadarsini, 2014, The chemistry of curcumin: from extraction to therapeutic agent, Molecules, 19, 20091, 10.3390/molecules191220091 · DOI · Paper page
  49. Rahmani, 2016, Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial, Phytother Res., 30, 1540, 10.1002/ptr.5659 · DOI
  50. Rogler, 1998, Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa, Gastroenterology, 115, 357, 10.1016/S0016-5085(98)70202-1 · DOI · Paper page
  51. Rubin, 2019, ACG clinical guideline: ulcerative colitis in adults, Am. J. Gastroenterol., 114, 384, 10.14309/ajg.0000000000000152 · DOI
  52. S W, 1859, Morbid appearances in the intestine of miss bankes, London Medical Gazette, 2, 264
  53. Sadeghi, 2020, The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis, Phytother Res., 34, 1123, 10.1002/ptr.6581 · DOI · Paper page
  54. Sahebkar, 2016, Curcumin downregulates human tumor necrosis factor-α levels: a systematic review and meta-analysis ofrandomized controlled trials, Pharmacol. Res., 107, 234, 10.1016/j.phrs.2016.03.026 · DOI
  55. Salomon, 2017, An integrative curcumin-mesalamine therapy for remission induction in mild-moderate active ulcerative colitis: an international, multi-center, randomized, double-blind, placebo-controlled trial, BMC Compl. Alternative Med., 17
  56. Sandborn, 2010, Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis, Gastroenterology, 138, 1286, 10.1053/j.gastro.2009.12.054 · DOI
  57. Schneider, 2015, Degradation of curcumin: from mechanism to biological implications, J. Agric. Food Chem., 63, 7606, 10.1021/acs.jafc.5b00244 · DOI
  58. Simadibrata, 2017, Efficacy of curcumin as adjuvant therapy to induce or maintain remission in ulcerative colitis patients: an evidence-based clinical review, Acta Med. Indones., 49, 363
  59. Singh, 2019, AGA technical review on the management of mild-to-moderate ulcerative colitis, Gastroenterology, 156, 769, 10.1053/j.gastro.2018.12.008 · DOI
  60. Singla, 2014, Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study, Journal of Crohn's & colitis, 8, 208, 10.1016/j.crohns.2013.08.006 · DOI
  61. Singla, 2014, Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study, J Crohns Colitis, 8, 208, 10.1016/j.crohns.2013.08.006 · DOI
  62. Sreedhar, 2016, Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease, Drug Discov. Today, 21, 843, 10.1016/j.drudis.2016.03.007 · DOI
  63. Ukil, 2003, Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis, Br. J. Pharmacol., 139, 209, 10.1038/sj.bjp.0705241 · DOI
  64. Ungaro, 2017, Ulcerative colitis, Lancet, 389, 1756, 10.1016/S0140-6736(16)32126-2 · DOI
  65. Wang, 2018, Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis, Immunopharmacol. Immunotoxicol., 40, 476, 10.1080/08923973.2018.1469145 · DOI
  66. Wei, 2021, Curcumin ameliorates DSS-induced colitis in mice by regulating the Treg/Th17 signaling pathway, Mol. Med. Rep., 23, 1, 10.3892/mmr.2020.11672 · DOI
  67. Wei, 2021, A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cells, J. Ethnopharmacol., 267, 113467, 10.1016/j.jep.2020.113467 · DOI
  68. Xu, 2004, Drug therapy for ulcerative colitis, World J. Gastroenterol., 10, 2311, 10.3748/wjg.v10.i16.2311 · DOI
  69. Yarlas, 2018, Health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis and remission status following short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study, Inflamm. Bowel Dis., 24, 450, 10.1093/ibd/izx041 · DOI

Cited by

Metadata

Authors
Yin, J., Wei, L., Wang, N., Li, X., & Miao, M.
Venue
Journal of Ethnopharmacology
Publisher
Elsevier BV
Published
2022-05
Volume
289
Pages
115041
ISSN
0378-8741
DOI
10.1016/j.jep.2022.115041
Cited by
45
References
6
Language
en
Licence
Funders
National Natural Science Foundation of China

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.